Quantcast

Latest Complix NV Stories

2014-03-26 04:21:14

HASSELT, Belgium, March 26, 2014 /PRNewswire/ -- Complix, a biopharmaceutical company focused on the discovery and development of Cell Penetrating Alphabodies(TM) (CPABs), a unique class of protein therapeutics that are active against intracellular disease targets, announces that its CEO Dr Mark Vaeck will present tomorrow at BioCapital Europe [http://www.biocapitaleurope.com/BioCapitalEurope/index.html ] 2014 in Amsterdam, the Netherlands (March 27th). Details of the...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.